NASDAQ:GNPX - Genprex Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$1.17 -0.05 (-4.10 %)
(As of 12/11/2018 01:54 AM ET)
Previous Close$1.22
Today's Range$1.17 - $1.29
52-Week Range$1.09 - $19.45
Volume9,300 shs
Average Volume150,140 shs
Market Capitalization$18.39 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Genprex, Inc., a clinical stage gene therapy company, develops drugs to treat cancer. Its lead product candidate is Oncoprex, an active anti-cancer agent that is in Phase II clinical trials for the treatment of non-small cell lung cancer (NSCLC). It also conducts preclinical research for developing Oncoprex to be administered with immunotherapies in NSCLC; and research into other tumor suppressor genes associated with chromosome. Genprex, Inc. was founded in 2009 and is based in Austin, Texas.

Receive GNPX News and Ratings via Email

Sign-up to receive the latest news and ratings for GNPX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:GNPX
Previous Symbol
CUSIPN/A
Phone512-537-7997

Debt

Debt-to-Equity RatioN/A
Current Ratio19.07
Quick Ratio19.07

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-3,310,000.00
Net MarginsN/A
Return on Equity-163.85%
Return on Assets-144.67%

Miscellaneous

Employees5
Outstanding Shares15,070,000
Market Cap$18.39 million
OptionableNot Optionable

Genprex (NASDAQ:GNPX) Frequently Asked Questions

What is Genprex's stock symbol?

Genprex trades on the NASDAQ under the ticker symbol "GNPX."

How were Genprex's earnings last quarter?

Genprex Inc (NASDAQ:GNPX) posted its quarterly earnings results on Tuesday, November, 20th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.13) by $0.02. View Genprex's Earnings History.

When is Genprex's next earnings date?

Genprex is scheduled to release their next quarterly earnings announcement on Tuesday, February 19th 2019. View Earnings Estimates for Genprex.

What price target have analysts set for GNPX?

1 Wall Street analysts have issued twelve-month price targets for Genprex's shares. Their predictions range from $3.00 to $3.00. On average, they expect Genprex's stock price to reach $3.00 in the next year. This suggests a possible upside of 156.4% from the stock's current price. View Analyst Price Targets for Genprex.

What is the consensus analysts' recommendation for Genprex?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genprex in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Genprex.

Has Genprex been receiving favorable news coverage?

News headlines about GNPX stock have trended somewhat positive this week, InfoTrie Sentiment reports. The research group identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Genprex earned a daily sentiment score of 1.2 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 7.0 out of 10, indicating that recent media coverage is likely to have an effect on the company's share price in the next several days.

Who are some of Genprex's key competitors?

Who are Genprex's key executives?

Genprex's management team includes the folowing people:
  • Mr. John Rodney Varner, Co-Founder, CEO, Sec. & Chairman (Age 61)
  • Dr. Julien L. Pham M.P.H., M.D., MPH, Pres & COO (Age 41)
  • Mr. Ryan M. Confer, Chief Financial Officer (Age 36)
  • Ms. Janice Stevens, VP of Clinical Operations
  • Dr. Jack A. Roth FACS, M.D., Chairman of Scientific & Medical Advisory Board

How do I buy shares of Genprex?

Shares of GNPX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Genprex's stock price today?

One share of GNPX stock can currently be purchased for approximately $1.17.

How big of a company is Genprex?

Genprex has a market capitalization of $18.39 million. Genprex employs 5 workers across the globe.

What is Genprex's official website?

The official website for Genprex is http://www.genprex.com.

How can I contact Genprex?

Genprex's mailing address is 1701 Trinity Street Suite 3.322, AUSTIN TX, 78712. The company can be reached via phone at 512-537-7997 or via email at [email protected]


MarketBeat Community Rating for Genprex (NASDAQ GNPX)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  65 (Vote Outperform)
Underperform Votes:  76 (Vote Underperform)
Total Votes:  141
MarketBeat's community ratings are surveys of what our community members think about Genprex and other stocks. Vote "Outperform" if you believe GNPX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GNPX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/11/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel